Dianthus Therapeutics Announces Two Poster Presentations For DNTH103 At The 10th Congress Of The European Academy Of Neurology June 29-July 2, 2024
Dianthus Therapeutics Announces Two Poster Presentations For DNTH103 At The 10th Congress Of The European Academy Of Neurology June 29-July 2, 2024
Dianthus Therapeutics宣布将在2024年6月29日至7月2日举行的第10届欧洲神经学院大会上举办两个关于DNTH103的海报展示。
Dianthus Therapeutics, Inc. (NASDAQ:DNTH), a clinical-stage biotechnology company dedicated to advancing the next generation of antibody complement therapeutics to treat severe autoimmune diseases, today announced two poster presentations for DNTH103 at the 10th Congress of the European Academy of Neurology (EAN), taking place June 29-July 2, 2024 in Helsinki.
Dianthus Therapeutics，Inc.（纳斯达克：DNTH）是一家临床生物技术公司，致力于推进下一代抗体补体治疗药物，用于治疗严重的自身免疫性疾病。今天宣布DNTH103在2024年6月29日至7月2日在赫尔辛基举行的第10届欧洲神经学学会（EAN）上展示两个海报报告。